Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us
Clinical trial report, Actinic (Solar) Keratosis Global Clinical Trials Review, H1, 2014" provides data on the Actinic (Solar) Keratosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Actinic (Solar) Keratosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
To Download Sample Report With TOC: http://www.researchmoz.com/enquiry.php?type=sample&repid=188581
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Actinic (Solar) Keratosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
To Browse a Full Report with TOC: http://www.researchmoz.us/actinic-solar-keratosis-global-clinical-trials-review-h1-2014-report.html
Table of Contents
List of Tables
List of Figures
Introduction
Actinic (Solar) Keratosis
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Actinic (Solar) Keratosis to Dermatology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Actinic (Solar) Keratosis to Dermatology Clinical Trials
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Actinic (Solar) Keratosis
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Actinic (Solar) Keratosis Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Actinic (Solar) Keratosis
Sep 26, 2013: FIELD Study 1 now complete - evaluating one year treatment outcomes of actinic keratosis after a combined lesion- and field-directed treatment approach with cryosurgery and ingenol mebutate gel
Sep 13, 2012: Dusa Pharma Demonstrates Positive Results In Phase II Actinic Keratoses Extremities Study
Sep 06, 2012: Moberg Derma Completes Recruitment For Phase II Study OF Limtop In Actinic Keratosis
Apr 24, 2012: Dusa Pharma Completes Enrollment In Phase II Studies Of Levulan Kerastick Photodynamic Therapy
Mar 14, 2012: New England Journal Of Medicine Reviews Benefits Of Leo Pharma's Ingenol Mebutate In Treatment Of Actinic Keratosis
All Reports of this Category Here: http://www.researchmoz.us/healthcare-market-reports-56.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
No comments:
Post a Comment